PMV Pharmaceuticals Inc (PMVP)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -55.274 | -30.454 | -14.7 | -16.596 | -24.363 | -26.398 |
| Return on Equity (%) | 76.021 | 43.48 | -23.863 | -17.327 | -26.44 | -29.238 |
| Return on Invested Capital (%) | -62.066 | -33.485 | -15.289 | -17.934 | -28.816 | -36.16 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 20.282 | 32.324 | 8.02 | 6.792 | 5.375 | 4.387 |
| Earnings Per Share | -5.823 | -8.323 | -0.769 | -1.273 | -1.602 | -1.34 |
| Cash Per Share | 10.062 | 24.057 | 8.071 | 3.796 | 2.366 | 0.733 |
| Working Capital Per Share | 19.891 | 32.032 | 8.003 | 6.363 | 5.16 | 3.759 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -5.822 | -8.32 | -0.769 | -1.273 | -1.602 | -1.34 |
| EBITDA Per Share | -5.822 | -8.32 | -0.769 | -1.273 | -1.602 | -1.34 |
| Free Cash Flow Per Share | -5.785 | -8.585 | -0.773 | -1.25 | -1.434 | -1.346 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 3.01M | 3.05M | 44.78M | 45.43M | 45.77M | 51.45M |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | 45.77M | N/A | N/A | N/A | 51.45M | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 79.17M |
| Price to Earnings Ratio | -1.21 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.21 |
| Price to Book Ratio | 0.37 |
| Dividend Yield | - |
| Shares Outstanding | 51.75M |
| Average Volume (1 week) | 122.69k |
| Average Volume (1 Month) | 226.27k |
| 52 Week Change | -48.72% |
| 52 Week High | 3.19 |
| 52 Week Low | 1.40 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
